Metabolism and Excretion of Intravenous, Radio-Labeled Amisulpride in Healthy, Adult Volunteers.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 161, doi. 10.2147/CPAA.S234256
- By:
- Publication type:
- Article
Works matching IS 11791438 AND DT 2019 AND VI 11
Results: 16
1
2
Perioperative Administration of Emend<sup>®</sup> (Aprepitant) at a Tertiary Care Children's Hospital: A 12-Month Survey.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 155, doi. 10.2147/CPAA.S221736
- By:
- Publication type:
- Article
3
A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 145, doi. 10.2147/CPAA.S208033
- By:
- Publication type:
- Article
4
Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 133, doi. 10.2147/CPAA.S172353
- By:
- Publication type:
- Article
5
Vitamin B12 deficiency presenting as pseudo-thrombotic microangiopathy: a case report and literature review.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 127, doi. 10.2147/CPAA.S207258
- By:
- Publication type:
- Article
6
Approach to residual dizziness after successfully treated benign paroxysmal positional vertigo: effect of a polyphenol compound supplementation.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 117, doi. 10.2147/CPAA.S210763
- By:
- Publication type:
- Article
7
Role of the pharmacist in improving inhaler technique and asthma management in rural areas in Jordan.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 103, doi. 10.2147/CPAA.S213271
- By:
- Publication type:
- Article
8
Novel approaches to treating advanced systemic mastocytosis.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 77, doi. 10.2147/CPAA.S206615
- By:
- Publication type:
- Article
9
Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 93, doi. 10.2147/CPAA.S193191
- By:
- Publication type:
- Article
10
Reproducibility of nasal allergen challenge responses in adults with allergic rhinitis.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 67, doi. 10.2147/CPAA.S184404
- By:
- Publication type:
- Article
11
Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 57, doi. 10.2147/CPAA.S202614
- By:
- Publication type:
- Article
12
Effects of formulation types on pharmacodynamics of warfarin in patients with cerebral infarction and dysphagia.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 51, doi. 10.2147/CPAA.S184232
- By:
- Publication type:
- Article
13
Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 39, doi. 10.2147/CPAA.S192687
- By:
- Publication type:
- Article
14
Assessing the effect of omega-3 fatty acid combined with vitamin D3 versus vitamin D3 alone on estradiol levels: a randomized, placebo-controlled trial in females with vitamin D deficiency.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 25, doi. 10.2147/CPAA.S182927
- By:
- Publication type:
- Article
15
Small-cell lung cancer growth inhibition: synergism between NMDA receptor blockade and chemotherapy.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 15, doi. 10.2147/CPAA.S183885
- By:
- Publication type:
- Article
16
Method development and validation of ursodiol and its major metabolites in human plasma by HPLC-tandem mass spectrometry.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 1, doi. 10.2147/CPAA.S187519
- By:
- Publication type:
- Article